The LTM pathway, which regulates immune cell trafficking across the endothelial barrier, is disrupted in HPV-positive cervical cancer due to the reduced expression of key genes such as HSPA5, CTNNB1, and NPM1. This evidence concerns the gene HSPA5 and cervical cancer.